Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

Author： Gerzeli Simone  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.4, 2012-04, pp. : 253-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma

By Rutten-van Mölken M.P.M.H.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 671-684

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

By Johansson Gunnar  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 695-708

Adis International

Access to resources Recommend Favorite

Salmeterol/fluticasone propionate cost effective in asthma

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite